DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /EpigeneticsEpigenetics
  5. /PARPPARP
  6. /FuzuloparibFuzuloparib
Chemical structure of CAS 1358715-18-0

Fuzuloparib

In Stock•Starting at $14 for 1 mg•Purity ≥ 98%
CAS No.1358715-18-0
MDL No.N/A
MFC22H16F4N6O2
MW472.40
InChI KeyXJGXCBHXFWBOTN-UHFFFAOYSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$14In Stock
5 mg98%$31In Stock
10 mg98%$50In Stock
50 mg98%$167In Stock
100 mg98%$282In Stock
250 mg98%$547In Stock
1 g98%$1469In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1358715-18-0
Product NameFuzuloparib
Heavy Atom Count34Rotatable Bond Count3
Atom Stereo Count0Bond Stereo Count0
HBA6HBD1
TPSA96.770 ŲCharge0
Exact Mass472.12709Complexity1476.52
pKa9.247XLogP2.919

Related Articles

Studies related to this compound and its mechanism of action

Discovery of Quinazoline-2,4(1H,3H)-dione Derivatives Containing a Piperizinone Moiety as Potent PARP-1/2 Inhibitors─Design, Synthesis, In Vivo Antitumor Activity, and X-ray Crystal Structure Analysis.

Journal of medicinal chemistry • Vol. 66, Issue 20 • 2023
PMID: 37843892DOI: 10.1021/acs.jmedchem.3c01152

Fuzuloparib: First Approval.

Drugs • Vol. 81, Issue 10 • 2021
PMID: 34118019PMC: PMC8380563DOI: 10.1007/s40265-021-01541-x

Pharmacologic characterization of fluzoparib, a novel poly(ADP-ribose) polymerase inhibitor undergoing clinical trials.

Cancer science • Vol. 110, Issue 3 • 2019
PMID: 30663191PMC: PMC6398880DOI: 10.1111/cas.13947

[A new psychoanaleptic agent in neurologic, cardiovascular and orthopedic rehabilitation. Double blind controlled study with placebo].

La Nouvelle presse medicale • Vol. 5, Issue 14 • 1976
PMID: 5703

Documentation

Similar Products

  • Simmiparib

    CAS No.1551355-46-4

  • Azd-2461

    CAS No.1174043-16-3

  • Olaparib

    CAS No.763113-22-0

  • Parpi

    CAS No.1919043-65-4

  • Venadaparib

    CAS No.1681017-83-3

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact